photo free
Home Images Vectors Videos

Stock image Oral Diabetes Medication

stock vector Diabetes management concept in flat style, vector

Diabetes Management Concept In Flat Style, Vector

Vector, 2.26MB, 4168 × 4167 eps
stock image White pills capsules and red thread heart shape on blue background. Concept medical treatment, Medicine for diabetes, heart diseases and High blood pressure.

White Pills Capsules And Red Thread Heart Shape On Blue Background. Concept Medical Treatment, Medicine For Diabetes, Heart Diseases And High Blood Pressure.

Image, 5.61MB, 5000 × 3333 jpg
stock image Close-up of a doctor giving you a pill

Close-up Of A Doctor Giving You A Pill

Image, 2.75MB, 8320 × 3826 jpg
stock image Drugs and syringes on the background of money

Drugs And Syringes On The Background Of Money

Image, 7.42MB, 4752 × 3168 jpg
stock vector Diabetes Mellitus Diabetic High Blood Sugar Complications and Treatment Stick Figure Pictogram Icons

Diabetes Mellitus Diabetic High Blood Sugar Complications And Treatment Stick Figure Pictogram Icons

Vector, 2.89MB, 4360 × 4000 eps
stock image Metformin Tablet box

Metformin Tablet Box

Image, 6.6MB, 3806 × 2592 jpg
stock image SWINDON, UK - JANUARY 10, 2021:  Packet of Sukkarto SR Metformin Hydrochloride 500mg Prolonged Release Tablets

SWINDON, UK - JANUARY 10, 2021: Packet Of Sukkarto SR Metformin Hydrochloride 500mg Prolonged Release Tablets

Image, 3.54MB, 3484 × 2529 jpg
stock image Gliclazide molecular structure isolated on white

Gliclazide Molecular Structure Isolated On White

Image, 0.53MB, 7000 × 3038 jpg
stock image Gliclazide molecular structure isolated on white

Gliclazide Molecular Structure Isolated On White

Image, 0.51MB, 7000 × 3038 jpg
stock image Prague, Czech Republic-June 27 2024: Metformin TEVA box of medication with Metformin Hydrochloride active substance by Teva Pharmaceuticals, used for treatment of diabetes

Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes

Image, 2.3MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - June 28 2024: METFORMIN TEVA box of medication with Metformin hydrochloride active substance by Teva Pharmaceuticals, used for treatment of type 2 diabetes, insulin resistance.

Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.

Image, 2.72MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN box of tablets with GLICLAZIDE active substance,used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.28MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: GLICLAZID ACTAVIS box of tablets with GLICLAZIDE active substance,used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: GLICLAZID ACTAVIS Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.21MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN box of tablets with GLICLAZIDE active substance,used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.23MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: JENTADUETO box of tablets with LINAGLIPTIN and METFORMIN active substances, used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.08MB, 4032 × 3024 jpg
stock image Prague,Czech republic-June 17 2024: Xigduo box of medication with Dapagliflozin active substance by AstraZeneca, used for treatment of Type 2 diabetes

Prague,Czech Republic-June 17 2024: Xigduo Box Of Medication With Dapagliflozin Active Substance By AstraZeneca, Used For Treatment Of Type 2 Diabetes

Image, 2.41MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS box of medication with METFORMIN active substance by VIATRIS,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes

Image, 2.27MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.28MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.4MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.09MB, 4032 × 3024 jpg
stock vector Empagliflozin molecule. It is antidiabetic medication, SGLT2 inhibitor. Structural chemical, dark blue background. Vector illustration

Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Structural Chemical, Dark Blue Background. Vector Illustration

Vector, 0.31MB, 6124 × 4082 eps
stock image Empagliflozin molecule. It is antidiabetic medication, SGLT2 inhibitor. Molecular model. 3D rendering. Illustration

Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Molecular Model. 3D Rendering. Illustration

Image, 6.03MB, 9000 × 4460 jpg
stock image Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA box of medication with ALOGLIPTIN active substance by TAKEDA,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes

Image, 2.04MB, 4032 × 3024 jpg
stock vector Glibenclamide, glyburide molecule. Sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. Structural chemical formula, dark blue background. Vector illustration

Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Dark Blue Background. Vector Illustration

Vector, 0.31MB, 6847 × 3651 eps
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.26MB, 3024 × 4032 jpg
stock image Prague, Czech Republic-June 27 2024: Metformin TEVA box of medication with Metformin Hydrochloride active substance by Teva Pharmaceuticals, used for treatment of diabetes

Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes

Image, 2.25MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - JULY 10 2024: Dursea box of medication with desmopressin active substance by Egis Pharmaceuticals, used for treatment of diabetes insipidus and nocturnal enuresis.

Prague, Czech Republic - JULY 10 2024: Dursea Box Of Medication With Desmopressin Active Substance By Egis Pharmaceuticals, Used For Treatment Of Diabetes Insipidus And Nocturnal Enuresis.

Image, 2.02MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - JULY 10 2024: Dursea box of medication with desmopressin active substance by Egis Pharmaceuticals, used for treatment of diabetes insipidus and nocturnal enuresis.

Prague, Czech Republic - JULY 10 2024: Dursea Box Of Medication With Desmopressin Active Substance By Egis Pharmaceuticals, Used For Treatment Of Diabetes Insipidus And Nocturnal Enuresis.

Image, 2.02MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS box of medication with METFORMIN active substance by VIATRIS,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes

Image, 2.21MB, 3024 × 4032 jpg
stock image Prague, Czech Republic-June 27 2024: Metformin TEVA box of medication with Metformin Hydrochloride active substance by Teva Pharmaceuticals, used for treatment of diabetes

Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes

Image, 2.39MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA box of tablets with SITAGLIPTIN and METFORMIN active substances by TEVA, used for treatment of type 2 diabetes.

Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.

Image, 2.3MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.37MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 1.95MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.32MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.32MB, 3024 × 4032 jpg
stock vector Empagliflozin molecule. It is antidiabetic medication, SGLT2 inhibitor. Skeletal chemical formula. Paper packaging for drugs. Vector illustration

Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Skeletal Chemical Formula. Paper Packaging For Drugs. Vector Illustration

Vector, 0.31MB, 6547 × 3819 eps
stock image Prague, Czech Republic - June 28 2024: METFORMIN TEVA box of medication with Metformin hydrochloride active substance by Teva Pharmaceuticals, used for treatment of type 2 diabetes, insulin resistance.

Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.

Image, 2.37MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - June 28 2024: METFORMIN TEVA box of medication with Metformin hydrochloride active substance by Teva Pharmaceuticals, used for treatment of type 2 diabetes, insulin resistance.

Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.

Image, 2.24MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: JENTADUETO box of tablets with LINAGLIPTIN and METFORMIN active substances, used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.17MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: THIOGAMMA ORAL box of medication with ALPHA-LIPOIC ACID active substance by WRWAG PHARMA,used for treatment of diabetic neuropathy,neuroprotection.

Prague,Czech Republic-August 10 2024: THIOGAMMA ORAL Box Of Medication With ALPHA-LIPOIC ACID Active Substance By WRWAG PHARMA,used For Treatment Of Diabetic Neuropathy,neuroprotection.

Image, 2.14MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.33MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.16MB, 4032 × 3024 jpg
stock vector Glibenclamide, glyburide molecule. Sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. Structural chemical formula, molecule model. Vector illustration

Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Molecule Model. Vector Illustration

Vector, 0.43MB, 5590 × 4472 eps
stock image Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN box of tablets with GLICLAZIDE active substance,used for treatment of type 2 diabetes, blood sugar control.

Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.

Image, 2.15MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: JANUVIA box of medication with SITAGLIPTIN active substance by MERCK,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes

Image, 2.45MB, 4032 × 3024 jpg
stock image Prague, Czech Republic-June 27 2024: Metformin TEVA box of medication with Metformin Hydrochloride active substance by Teva Pharmaceuticals, used for treatment of diabetes

Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes

Image, 2.28MB, 4032 × 3024 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.22MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.15MB, 3024 × 4032 jpg
stock image Prague, Czech Republic - July 10 2024: RYBELSUS box of medication with SEMAGLUTIDE active substance by NOVO NORDISK, used for treatment of type 2 diabetes and blood sugar control.

Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.

Image, 2.24MB, 3024 × 4032 jpg
stock image Prague,Czech Republic-August 10 2024: THIOGAMMA ORAL box of medication with ALPHA-LIPOIC ACID active substance by WRWAG PHARMA,used for treatment of diabetic neuropathy,neuroprotection.

Prague,Czech Republic-August 10 2024: THIOGAMMA ORAL Box Of Medication With ALPHA-LIPOIC ACID Active Substance By WRWAG PHARMA,used For Treatment Of Diabetic Neuropathy,neuroprotection.

Image, 2.25MB, 4032 × 3024 jpg
Page 1 >> Next